Ilex Medical Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was ILS 221.68 million compared to ILS 200.44 million a year ago. Net income was ILS 8.89 million compared to ILS 19.16 million a year ago. Basic earnings per share from continuing operations was ILS 0.79 compared to ILS 1.7 a year ago. Diluted earnings per share from continuing operations was ILS 0.79 compared to ILS 1.7 a year ago.
For the nine months, sales was ILS 646.83 million compared to ILS 639.77 million a year ago. Net income was ILS 28.44 million compared to ILS 63.93 million a year ago. Basic earnings per share from continuing operations was ILS 2.54 compared to ILS 5.67 a year ago. Diluted earnings per share from continuing operations was ILS 2.54 compared to ILS 5.67 a year ago.